Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 6 de 6
Filter
Add more filters










Database
Language
Publication year range
1.
J Dairy Sci ; 105(9): 7705-7718, 2022 Sep.
Article in English | MEDLINE | ID: mdl-35879165

ABSTRACT

Mastitis in cattle is a major health problem as well as incurring high costs for the dairy industry. To assess the suitability of precision-cut bovine udder slices (PCBUS) for bovine mastitis studies, we infected PCBUS with 2 different Staphylococcus aureus strains. Accordingly, we investigated both the tissue response to infection based on immune mediators at the mRNA and protein levels and the invasion of bacteria within the tissue. The studied proteins represent immune mediators of early inflammation [IL-1ß, tumor necrosis factor-α (TNF-α), prostaglandin E2 (PGE2)] and showed a time-dependent increase in concentration. Infection of PCBUS with S. aureus resulted in increased expression of proinflammatory cytokines and chemokines such as TNF-α, C-C motif chemokine ligand 20 (CCL20), IL-1ß, IL-6, and IL-10, but not C-X-C motif chemokine ligand 8 (CXCL8), lingual antimicrobial peptide (LAP), or S100 calcium binding protein A9 (S100A9) at the mRNA level. To compare the data acquired with this model, we carried out investigations on primary bovine mammary epithelial cells. Our results showed that the immune responses of both models-PCBUS and primary bovine mammary epithelial cells-were similar. In addition, investigations using PCBUS enabled us to demonstrate adherence of bacteria in the physiological cell network. These findings support the use of PCBUS in studies designed to further understand the complex pathophysiological processes of infection and inflammation in bovine mastitis and to investigate alternative therapies for mastitis.


Subject(s)
Cattle Diseases , Mastitis, Bovine , Staphylococcal Infections , Animals , Bacteria , Cattle , Cattle Diseases/pathology , Chemokines , Epithelial Cells/microbiology , Female , Immunologic Factors , Inflammation/pathology , Inflammation/veterinary , Ligands , Mammary Glands, Animal/microbiology , Mastitis, Bovine/microbiology , RNA, Messenger , Staphylococcal Infections/veterinary , Staphylococcus aureus/physiology , Tumor Necrosis Factor-alpha
2.
Sci Rep ; 10(1): 5380, 2020 03 25.
Article in English | MEDLINE | ID: mdl-32214122

ABSTRACT

Dogs share many chronic morbidities with humans and thus represent a powerful model for translational research. In comparison to rodents, the canine ganglioside metabolism more closely resembles the human one. Gangliosides are components of the cell plasma membrane playing a role in neuronal development, intercellular communication and cellular differentiation. The present in vitro study aimed to characterize structural and functional changes induced by GM1 ganglioside (GM1) in canine dorsal root ganglia (DRG) neurons and interactions of GM1 with nerve growth factor (NGF) and fibroblast growth factor (FGF2) using immunofluorescence for several cellular proteins including neurofilaments, synaptophysin, and cleaved caspase 3, transmission electron microscopy, and electrophysiology. GM1 supplementation resulted in increased neurite outgrowth and neuronal survival. This was also observed in DRG neurons challenged with hypoxia mimicking neurodegenerative conditions due to disruptions of energy homeostasis. Immunofluorescence indicated an impact of GM1 on neurofilament phosphorylation, axonal transport, and synaptogenesis. An increased number of multivesicular bodies in GM1 treated neurons suggested metabolic changes. Electrophysiological changes induced by GM1 indicated an increased neuronal excitability. Summarized, GM1 has neurotrophic and neuroprotective effects on canine DRG neurons and induces functional changes. However, further studies are needed to clarify the therapeutic value of gangliosides in neurodegenerative diseases.


Subject(s)
Fibroblast Growth Factor 2/metabolism , G(M1) Ganglioside/metabolism , Nerve Growth Factor/metabolism , Nerve Growth Factors/metabolism , Animals , Cell Death/drug effects , Cell Survival/drug effects , Cells, Cultured , Dogs , Ganglia, Spinal/cytology , Ganglia, Spinal/metabolism , Ganglia, Spinal/physiology , Gangliosides/metabolism , Neurons/metabolism , Neuroprotective Agents/pharmacology
3.
Cell Microbiol ; 18(4): 536-45, 2016 Apr.
Article in English | MEDLINE | ID: mdl-26418545

ABSTRACT

Neutrophils store large quantities of neutrophil serine proteases (NSPs) that contribute, via multiple mechanisms, to antibacterial immune defences. Even though neutrophils are indispensable in fighting Staphylococcus aureus infections, the importance of NSPs in anti-staphylococcal defence is yet unknown. However, the fact that S. aureus produces three highly specific inhibitors for NSPs [the extracellular adherence proteins (EAPs) Eap, EapH1 and EapH2], suggests that these proteases are important for host defences against this bacterium. In this study we demonstrate that NSPs can inactivate secreted virulence factors of S. aureus and that EAP proteins function to prevent this degradation. Specifically, we find that a large group of S. aureus immune-evasion proteins is vulnerable to proteolytic inactivation by NSPs. In most cases, NSP cleavage leads to functional inactivation of virulence proteins. Interestingly, proteins with similar immune-escape functions appeared to have differential cleavage sensitivity towards NSPs. Using targeted mutagenesis and complementation analyses in S. aureus, we demonstrate that all EAP proteins can protect other virulence factors from NSP degradation in complex bacterial supernatants. These findings show that NSPs inactivate S. aureus virulence factors. Moreover, the protection by EAP proteins can explain why this antibacterial function of NSPs was masked in previous studies. Furthermore, our results indicate that therapeutic inactivation of EAP proteins can help to restore the natural host immune defences against S. aureus.


Subject(s)
Bacterial Proteins/metabolism , Immune Evasion , Neutrophils/enzymology , Serine Proteases/metabolism , Serine Proteinase Inhibitors/metabolism , Staphylococcus aureus/immunology , Virulence Factors/metabolism , Cells, Cultured , Humans , Neutrophils/immunology , Proteolysis , Staphylococcus aureus/pathogenicity , Staphylococcus aureus/physiology
4.
J Antimicrob Chemother ; 59(4): 600-6, 2007 Apr.
Article in English | MEDLINE | ID: mdl-17329268

ABSTRACT

OBJECTIVES: To date, very little is known about lincosamide resistance plasmids in staphylococci with only a single lnu(A)-carrying staphylococcal plasmid having been sequenced completely. The aim of this study was to characterize small lnu(A)-carrying plasmids isolated from bovine coagulase-negative staphylococci (CoNS). METHODS: Nine CoNS isolates with MICs of the lincosamide pirlimycin of 1-4 mg/L were tested for the presence of the lnu(A) gene. Its location was determined by Southern-blot hybridization. The lnu(A)-carrying plasmids were transformed into Staphylococcus aureus RN4220 and compared by restriction mapping and subsequent sequencing. Selected plasmids were investigated for their copy number and their lnu(A) gene expression via RT real-time PCR. RESULTS: The lnu(A) gene was detected on plasmids in all isolates. Sequence analysis revealed that these plasmids carried a rep gene, coding for the replication initiator protein, and the resistance gene lnu(A), coding for a lincosamide nucleotidyltransferase. While the Lnu(A) proteins were closely related (91.3-100% amino acid identity), the Rep proteins differed distinctly (27.4-100% amino acid identity), but showed similarity (81.4-98.5%) to Rep proteins of other small staphylococcal resistance plasmids. Sequence features of rolling-circle plasmids, such as the single-strand (ssoA) and double-strand (dso) origins of replication, were identified. For two plasmid types detected, the lincosamide resistance level varied with regard to the amounts of lnu(A) transcripts detected. CONCLUSIONS: Structurally different lnu(A)-carrying plasmids were detected in various CoNS species. The detection of the same lnu(A) gene in different plasmid backbones suggested the exchange of the gene via interplasmid recombinational events.


Subject(s)
Anti-Bacterial Agents/pharmacology , Macrolides/pharmacology , Nucleotidyltransferases/genetics , Staphylococcus aureus/enzymology , Staphylococcus aureus/genetics , Animals , Blotting, Southern , Cattle , DNA, Bacterial/genetics , Drug Resistance, Bacterial/genetics , Female , Gene Dosage , Gene Expression Regulation, Bacterial/genetics , Lincosamides , Mastitis, Bovine/microbiology , Microbial Sensitivity Tests , Reverse Transcriptase Polymerase Chain Reaction , Reverse Transcription , Staphylococcus aureus/drug effects , Transformation, Bacterial
5.
Xenobiotica ; 35(10-11): 927-41, 2005.
Article in English | MEDLINE | ID: mdl-16393853

ABSTRACT

Administration of drugs by inhalation opens new possibilities for entry into the systemic circulation and cultures of porcine pulmonary epithelial cells (PECs) may prove to be valuable in the prediction of pulmonary metabolism of drugs in humans. This paper, therefore, reports a method for the routine isolation and cultivation of PECs from slaughterhouse animals. On average 1.5x10(6) cells g-1 tissue were isolated by discontinuous density-gradient centrifugation. Cells were subsequently cultivated on collagen-coated plates and characterized by staining for alkaline phosphatase, by tannic acid staining of lamellar bodies and by surfactant protein (SP) expression at days 0, 3 and 6 in culture. Over 70% of purified cells were positive for SP-C and tannic acid staining and thus defined as epithelial cells of alveolar origin (AECs). The AEC phenotype was also confirmed by specific binding of marker lectins (Maclura pomifera and Helix pomatia) and by studying gene expression and activity of cytochrome P450 monooxygenases. Testosterone, ethoxyresorufin, benzyloxyresorufin and verapamil were used as substrates for cytochrome P450-catalysed oxidations and cultured cells were found to be differentiated as well as metabolically competent during cultivation. Therefore, this culture system enables in depth pulmonary biotransformation and toxicity studies.


Subject(s)
Cell Culture Techniques/methods , Cell Separation/methods , Centrifugation/methods , Lung/cytology , Lung/metabolism , Respiratory Mucosa/cytology , Respiratory Mucosa/metabolism , Animals , Cells, Cultured , Lectins/metabolism , Swine , Testosterone/metabolism
6.
Article in English | MEDLINE | ID: mdl-15458493

ABSTRACT

Staphylococcus aureus strain Newman was investigated for changes in its growth pattern, its morphology and its viability when grown in the presence of 3 microg/ml florfenicol (Ff). This concentration corresponds to the 0.75-fold strain-specific minimum inhibitory concentration (MIC). Under these conditions, S. aureus Newman showed a distinct retardation in its growth pattern and 20% dead cells were detected in a fluorescence microscopic viability assay. However, bactericidal activity - defined as a 3-log drop in the staphylococcal population - was not recorded at this Ff concentration. Further analysis of the cell wall revealed a significant increase in cell wall thickness of S. aureus Newman when grown in the presence of 3 microg/ml Ff. This might result in a compression of the protoplast with subsequent disruption of single staphylococcal cells. Accordingly, 20% of the staphylococcal cells analysed by electron microscopy proved to be disrupted. These observations suggest that Ff can cause a thickening of the cell wall accompanied by impaired viability of the staphylococcal cells.


Subject(s)
Anti-Bacterial Agents/pharmacology , Staphylococcus aureus/drug effects , Thiamphenicol/analogs & derivatives , Thiamphenicol/pharmacology , Animals , Anti-Bacterial Agents/administration & dosage , Anti-Bacterial Agents/therapeutic use , Cattle , Cattle Diseases/drug therapy , Cattle Diseases/microbiology , Microbial Sensitivity Tests/veterinary , Respiratory Tract Infections/drug therapy , Respiratory Tract Infections/veterinary , Staphylococcal Infections/drug therapy , Staphylococcal Infections/veterinary , Staphylococcus aureus/classification , Staphylococcus aureus/physiology , Staphylococcus aureus/ultrastructure , Swine , Swine Diseases/drug therapy , Swine Diseases/microbiology , Thiamphenicol/administration & dosage , Thiamphenicol/therapeutic use
SELECTION OF CITATIONS
SEARCH DETAIL
...